Biopharmaceuticals are often favored in modern medicine due to their ability to:

Biopharmaceuticals are increasingly preferred in modern medical treatments primarily because they tend to exhibit fewer side effects compared to conventional drugs. This is attributed to their complex structure and mechanisms of action, which are often more targeted. Biopharmaceuticals, such as monoclonal antibodies or therapeutic proteins, are designed to interact specifically with biological targets, minimizing the impact on non-target tissues. This specificity can lead to a more favorable safety profile, as many conventional drugs may affect multiple pathways or systems in the body, resulting in a broader range of side effects.

The other choices present less accurate characteristics of biopharmaceuticals. While some biopharmaceuticals can be costly due to the complexities of their development and production, they do not uniformly represent a lower cost compared to conventional drugs. Additionally, biopharmaceuticals are inherently tied to biological systems for their production, often relying on living organisms for synthesis. Lastly, biopharmaceuticals can be effective against both infectious and non-infectious diseases, making them versatile in application rather than limited to one category.